lu 135252 has been researched along with Cirrhosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dieterich, M; Gögebakan, O; Kossmehl, P; Kreutz, R; Rothermund, L; Vetter, R; Yagil, C; Yagil, Y | 1 |
Arck, PC; Godes, M; Herzfeld, S; Hocher, B; Kalk, P; Mach, A; Nafz, B; Neumayer, HH; Slowinski, T; Wiesner, D | 1 |
Amann, K; El-Shakmak, A; Gross, ML; Hansen, A; Heiss, N; Münter, K; Ritz, E; Szabo, A; Weckbach, M | 1 |
Angelini, A; Basso, C; Della Barbera, M; Iliceto, S; Kirchengast, M; Thiene, G | 1 |
4 other study(ies) available for lu 135252 and Cirrhosis
Article | Year |
---|---|
Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium-Binding Proteins; Calcium-Transporting ATPases; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium Chloride; Ventricular Dysfunction, Left | 2002 |
ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
Topics: Animals; Disease Progression; Endothelin Receptor Antagonists; Fibrosis; Kidney; Kidney Tubules; Male; Organ Size; Phenylpropionates; Polycystic Kidney Diseases; Propionates; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renal Circulation | 2003 |
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterioles; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Collagen Type IV; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression; Heart; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Transforming Growth Factor beta | 2004 |
Endothelin A-receptor antagonist administration immediately after experimental myocardial infarction with reperfusion does not affect scar healing in dogs.
Topics: Administration, Oral; Analysis of Variance; Animals; Dogs; Endothelin Receptor Antagonists; Fibrosis; Image Processing, Computer-Assisted; Immunohistochemistry; Injections, Intravenous; Male; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Transforming Growth Factor beta | 2002 |